Pharmacological evaluation of 3,4-dimethoxyphenylacetamide.
D000081:Acetamides; D000085:Acetates / Q000494:pharmacology*; D000577:Amides / Q000494:pharmacology*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D000928:Antidepressive Agents / Q000494:pharmacology*; D001555:Benzene Derivatives; D001786:Blood Glucose / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D006591:Hexobarbital / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000081:Acetamides; D000085:Acetates; D000577:Amides; D000927:Anticonvulsants; D000928:Antidepressive Agents; D001555:Benzene Derivatives; D001786:Blood Glucose; D010276:Parasympatholytics; D002784:Cholesterol; D006591:Hexobarbital